Education
About Us
Working with TipRanks
Follow Us
Natera (NTRA)
NASDAQ:NTRA
NTRA Analyst Ratings
Strong Buy
15 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NTRA Stock 12 Month Forecast
Average Price Target
$194.57
▲(25.05% Upside)
| Highest Price Target$211.00 | Average Price Target$194.57 | Lowest Price Target$175.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Craig-Hallum
Reiterated
02/28/25
Robert W. Baird
Reiterated
02/28/25
Jefferies
Reiterated
02/28/25
Piper Sandler
Reiterated
02/28/25
BTIG
Reiterated
02/28/25
Barclays
Reiterated
02/28/25
Leerink Partners
Reiterated
02/28/25
TD Cowen
Reiterated
02/27/25
Guggenheim
Reiterated
02/27/25
Canaccord Genuity
$180
Buy
15.69%
Upside
Reiterated
02/25/25
Natera's Strong Market Position and Growth Potential Drive Buy Rating Amid Expanded Medicare Coverage and Robust Patent ProtectionsWe reiterate our BUY rating on Natera (NTRA) shares and maintain our price target at $180. Before the market open on the company announced its Signatera test has met coverage requirements from the Services’ (CMS) Molecular Diagnostics Services (MolDX) Program for patients with non-small cell lung cancer (NSCLC). This expands upon preexisting Medicare coverage of Signatera for monitoring of immunotherapy, a common form of treatment for NSCLC in the adjuvant and metastatic settings. Moreover, this new coverage is incremental to Signatera's current coverage in colorectal cancer (CRC), breast cancer, muscle invasive bladder cancer (MIBC), ovarian cancer and immunotherapy monitoring of solid tumors. In our view, this new coverage should drive revenue growth (potentially in the near term) and help the company obtain commercial payer coverage for Signatera as well.
Raymond James
$175
Buy
12.48%
Upside
Reiterated
02/10/25
Raymond James reiterates Outperform Rating on Natera (NTRA)Raymond James analyst Andrew Cooper reiterated an Outperform rating and $175.00 price target on Natera (NASDAQ: NTRA).
Goldman Sachs
$160→$190
Buy
22.12%
Upside
Reiterated
01/28/25
Natera (NTRA) PT Raised to $190 at Goldman SachsGoldman Sachs analyst Matthew Sykes raised the price target on Natera (NASDAQ: NTRA) to $190.00 (from $160.00) while maintaining a Buy rating.
Bernstein
$200
Buy
28.54%
Upside
Reiterated
01/14/25
Bernstein Keeps Their Buy Rating on Natera (NTRA)
J.P. Morgan
$160→$200
Buy
28.54%
Upside
Reiterated
12/13/24
Natera price target raised to $200 from $160 at JPMorganNatera price target raised to $200 from $160 at JPMorgan
Best Analysts Covering Natera
Which Analyst Should I Follow If I Want to Buy NTRA and Sell After:
1 Month
xxx
Success Rate
13/18 ratings generated profit
Average Return
+9.62%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 72.22% of your transactions generating a profit, with an average return of +9.62% per trade.
3 Months
xxx
Success Rate
12/18 ratings generated profit
Average Return
+13.57%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +13.57% per trade.
1 Year
Success Rate
14/17 ratings generated profit
Average Return
+51.53%
reiterated a buy rating 8 months ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +51.53% per trade.
2 Years
xxx
Success Rate
20/23 ratings generated profit
Average Return
+130.61%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.96% of your transactions generating a profit, with an average return of +130.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NTRA Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
0
0
0
0
0
Buy
25
24
20
32
31
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
24
20
32
31
Each month's total comprises the sum of three months' worth of ratings.
NTRA Financial Forecast
NTRA Stock Forecast FAQ
What is NTRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Natera’s 12-month average price target is $194.57.
What is NTRA’s upside potential, based on the analysts’ average price target?
Natera has 25.05% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NTRA a Buy, Sell or Hold?
Natera has a consensus rating of Strong Buy which is based on 15 buy ratings, 0 hold ratings and 0 sell ratings.
What is Natera’s price target?
The average price target for Natera is $194.57. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $211.00 ,the lowest forecast is $175.00. The average price target represents 25.05% Increase from the current price of $155.59.
The highest analyst price target is $211.00 ,the lowest forecast is $175.00. The average price target represents 25.05% Increase from the current price of $155.59.
What do analysts say about Natera?
Natera’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of NTRA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.